AV
Ashwani Verma UBS Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
43
Avg Return
Past Year
Past Year
3.2%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
70.3%
Neutral
29.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Technology
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Technology
Scientific & Technical Instruments
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $69 |
3%
downside
| 2 | – |
–
| 6 Mar ‘26 3 months ago |
|
|
|
Buy
Maintained
| $705 |
28%
upside
| 7 | +9.7% |
0
%
| 5 Mar ‘26 3 months ago |
|
|
|
Buy
Maintained
| $251 |
1%
downside
| 2 | -3.6% |
0
%
| 24 Feb ‘26 3 months ago |
|
|
|
Neutral
Downgraded
| $46 |
35%
upside
| 3 | +16% |
0
%
| 11 Feb ‘26 4 months ago |
|
|
|
Buy
Maintained
| $178 |
12%
upside
| 5 | +5.2% |
0
%
| 23 Jan ‘26 4 months ago |
|
|
|
Buy
Maintained
| $215 |
121%
upside
| 1 | -18% |
0
%
| 6 Jan ‘26 5 months ago |
|
|
|
Buy
Maintained
| $40 |
88%
upside
| 5 | +9.9% |
0
%
| 6 Jan ‘26 5 months ago |
|
|
|
Neutral
Initiated
| $95 |
14%
upside
| 1 | – |
–
| 16 Dec ‘25 6 months ago |
|
|
|
Buy
Maintained
| $48 |
35%
upside
| 2 | -27% |
0
%
| 8 Dec ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| $11 |
9%
downside
| 2 | -32% |
0
%
| 26 Nov ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| $188 |
18%
downside
| 1 | +30% |
–
| 24 Nov ‘25 6 months ago |
|
|
|
Buy
Maintained
| $10 |
136%
upside
| 1 | -30% |
0
%
| 18 Nov ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $220 |
1%
downside
| 1 | – |
–
| 7 Nov ‘25 7 months ago |
|
|
|
Neutral
Maintained
| $40 |
25%
downside
| 3 | – |
–
| 6 Nov ‘25 7 months ago |
|
|
|
Neutral
Downgraded
| $20 |
8%
downside
| 2 | +30% |
0
%
| 28 Oct ‘25 7 months ago |
|
|
|
Buy
Maintained
| $26 |
23%
downside
| 2 | +32% |
0
%
| 24 Sep ‘25 8 months ago |
|
|
|
Neutral
Maintained
| $18 |
46%
downside
| 1 | – |
–
| 28 Jul ‘25 10 months ago |
|
|
|
Buy
Upgraded
| $42 |
5%
downside
| 2 | -5% |
0
%
| 17 Jun ‘25 12 months ago |
|